Amalgamated Financial Boosts Share Repurchase Program by $31.4M, Totaling $40M
AMAL sits 75% above its 52-week low of $25.13.
Summary
Amalgamated Financial's Board approved an additional $31.4 million for its share repurchase program, increasing the total authorization to $40 million.
Key Events · Financing and Capital Events · AMAL
-
Increased Share Repurchase Authorization
The Board authorized an additional $31.4 million for share repurchases, bringing the total available under the existing program to $40 million.
-
Significant Capital Allocation
The total authorized amount represents approximately 3% of the company's current market capitalization, signaling a commitment to returning capital to shareholders.
-
No Expiration Date
The share repurchase program has no set expiration date, allowing flexibility in execution based on market conditions.
Analysis · AMAL · Finance
The Board's authorization of an additional $31.4 million for share repurchases, bringing the total program to $40 million, is a significant capital allocation decision. This amount represents approximately 3% of the company's market capitalization. While share repurchases can boost earnings per share and signal management confidence, this move comes after recent reports of a surge in nonperforming assets, indicating a strategic balance between returning capital to shareholders and managing credit risk. The decision to authorize repurchases while the stock trades near its 52-week high suggests management's belief in the company's underlying value.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1020 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMAL was trading at $44.10 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $25.13 to $44.25. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.